Short Interest in Basilea Pharmaceutica AG (OTCMKTS:BPMUF) Rises By 4,000.0%

Basilea Pharmaceutica AG (OTCMKTS:BPMUF - Get Free Report) was the target of a significant growth in short interest during the month of May. As of May 15th, there was short interest totalling 4,100 shares, a growth of 4,000.0% from the April 30th total of 100 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average trading volume of 0 shares, the days-to-cover ratio is presently ∞ days.

Basilea Pharmaceutica Price Performance

Shares of Basilea Pharmaceutica stock remained flat at $47.50 during mid-day trading on Friday. The company has a fifty day simple moving average of $49.87 and a 200-day simple moving average of $51.83. Basilea Pharmaceutica has a one year low of $47.50 and a one year high of $54.00. The company has a current ratio of 4.10, a quick ratio of 3.27 and a debt-to-equity ratio of 5.70.

About Basilea Pharmaceutica

Basilea Pharmaceutica AG, a commercial-stage biopharmaceutical company, focuses on the development of products that address the medical needs in the therapeutic areas of oncology and anti-infectives. The company offers Cresemba, an intravenous and antifungal drug for the treatment of invasive aspergillosis and mucormycosis in the United States, and the European Union.